A recent scientific statement from the American Heart Association, published in the journal Circulation, places greater emphasis on right ventricular function in both research and clinical care for pulmonary hypertension (PH).
Two scientists from the German Center for Lung Research (DZL) have been awarded the prestigious René Baumgart Foundation Research Prize. The award ceremony took place during the 66th Congress of the German Respiratory Society in...
Researchers have uncovered evidence of unexpected links between breast cancer and pulmonary arterial hypertension. The study opens new perspectives for understanding both diseases.
The ion channel Piezo1 plays a central role in the development of pulmonary hypertension, as shown by a new study. The findings could enable the development of innovative treatment approaches.
The ZENITH study shows promising results for Sotatercept in the treatment of advanced pulmonary arterial hypertension (PAH) and represents a significant advancement in the therapy of this severe disease.
DZL researchers have developed a new theory on the development of pulmonary arterial hypertension (PAH). The focus is on lysosomes – cellular organelles responsible for metabolism and waste disposal.
**Promising Results for Seralutinib in Pulmonary Arterial Hypertension** A recent international study shows that the new drug Seralutinib significantly reduces symptoms of pulmonary arterial hypertension, especially in advanced stages. This development offers new hope for...
An interdisciplinary team at JLU has unveiled genetic networks involved in right heart failure, a condition closely tied to lung diseases. Their research offers new insights and potential treatment targets for this severe illness.
The German Research Foundation (DFG) has approved the third funding period for the Giessen Collaborative Research Centre 1213 on cardiopulmonary research - the researchers led by DZL scientist Prof. Dr Norbert Weißmann can thus build...
DZL scientist Prof. Dr. Soni Savai Pullamsetti and her team have discovered signalling pathways involved in developing right heart failure in patients with pulmonary hypertension. The findings provide new biomarkers for diagnosis and targets for...
The National Academy of Sciences Leopoldina is Germany's oldest scientific and medical-learned society. DZL researcher Prof. Pullamsetti was admitted to the prestigious Leopoldina.
DZL researchers have found that inhibiting a signaling pathway reduces pathological remodeling of the right ventricle in pulmonary hypertension.
